Warrants Finder
Your selection:
112 Results
| MN6DYF |  | Halozyme Therapeutics Inc./OS/Call [75]/MS | - | - | 75.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 03/19/2027 | 0.100 | Morgan Stanley | |
| JZ9Y2M | Halozyme Therapeutics Inc./OS/Call [76]/JPMD | - | - | 76.000 | call | Halozyme Therapeutics Inc. | - | 51.624% | 0.664 | -0.037 | 5.803 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE0YPD | Halozyme Therapeutics Inc./OS/Call [76]/JPMD | - | - | 76.000 | call | Halozyme Therapeutics Inc. | - | 52.975% | 0.657 | -0.024 | 3.852 | 12/18/2026 | 0.100 | JP Morgan | ||
| JZ91T3 | Halozyme Therapeutics Inc./OS/Call [78]/JPMD | - | - | 78.000 | call | Halozyme Therapeutics Inc. | - | 47.445% | 0.625 | -0.035 | 6.530 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE111M | Halozyme Therapeutics Inc./OS/Call [78]/JPMD | - | - | 78.000 | call | Halozyme Therapeutics Inc. | - | 50.529% | 0.626 | -0.024 | 4.138 | 12/18/2026 | 0.100 | JP Morgan | ||
| JZ97TL | Halozyme Therapeutics Inc./OS/Call [80]/JPMD | - | - | 80.000 | call | Halozyme Therapeutics Inc. | - | 46.697% | 0.573 | -0.036 | 7.018 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE111P | Halozyme Therapeutics Inc./OS/Call [80]/JPMD | - | - | 80.000 | call | Halozyme Therapeutics Inc. | - | 49.525% | 0.598 | -0.024 | 4.330 | 12/18/2026 | 0.100 | JP Morgan | ||
| JY2PZL | Halozyme Therapeutics Inc./OS/Call [80]/JPMD | - | - | 80.000 | call | Halozyme Therapeutics Inc. | - | 54.654% | 0.564 | -0.059 | 8.337 | 08/21/2026 | 0.100 | JP Morgan | ||
| MM26P4 | | Halozyme Therapeutics Inc./OS/Call [80]/MS | - | - | 80.000 | call | Halozyme Therapeutics Inc. | - | 49.608% | 0.598 | -0.024 | 4.326 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MM26P3 | | Halozyme Therapeutics Inc./OS/Call [80]/MS | - | - | 80.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM5J5Z | | Halozyme Therapeutics Inc./OS/Call [80]/MS | - | - | 80.000 | call | Halozyme Therapeutics Inc. | - | 47.591% | 0.573 | -0.036 | 6.901 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN030Y | | Halozyme Therapeutics Inc./OS/Call [80]/MS | - | - | 80.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN6DYG | | Halozyme Therapeutics Inc./OS/Call [80]/MS | - | - | 80.000 | call | Halozyme Therapeutics Inc. | - | 50.876% | 0.586 | -0.019 | 3.544 | 03/19/2027 | 0.100 | Morgan Stanley | |
| JE04WR | Halozyme Therapeutics Inc./OS/Call [82]/JPMD | - | - | 82.000 | call | Halozyme Therapeutics Inc. | - | 47.144% | 0.520 | -0.036 | 7.372 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE111L | Halozyme Therapeutics Inc./OS/Call [82]/JPMD | - | - | 82.000 | call | Halozyme Therapeutics Inc. | - | 49.516% | 0.524 | -0.023 | 4.655 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE0D0P | Halozyme Therapeutics Inc./OS/Call [84]/JPMD | - | - | 84.000 | call | Halozyme Therapeutics Inc. | - | 48.248% | 0.471 | -0.037 | 7.598 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE0YP9 | Halozyme Therapeutics Inc./OS/Call [84]/JPMD | - | - | 84.000 | call | Halozyme Therapeutics Inc. | - | 49.115% | 0.536 | -0.024 | 4.642 | 12/18/2026 | 0.100 | JP Morgan | ||
| JY2PZU | Halozyme Therapeutics Inc./OS/Call [85]/JPMD | - | - | 85.000 | call | Halozyme Therapeutics Inc. | - | 56.570% | 0.414 | -0.059 | 9.479 | 08/21/2026 | 0.100 | JP Morgan | ||
| MM2SE3 | | Halozyme Therapeutics Inc./OS/Call [85]/MS | - | - | 85.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM2SE0 | | Halozyme Therapeutics Inc./OS/Call [85]/MS | - | - | 85.000 | call | Halozyme Therapeutics Inc. | - | 50.456% | 0.521 | -0.024 | 4.611 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MM5J60 | | Halozyme Therapeutics Inc./OS/Call [85]/MS | - | - | 85.000 | call | Halozyme Therapeutics Inc. | - | 52.956% | 0.459 | -0.040 | 7.083 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN030Z | | Halozyme Therapeutics Inc./OS/Call [85]/MS | - | - | 85.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN7LDD | | Halozyme Therapeutics Inc./OS/Call [85]/MS | - | - | 85.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 03/19/2027 | 0.100 | Morgan Stanley | |
| JZ9ZEA | Halozyme Therapeutics Inc./OS/Call [86]/JPMD | - | - | 86.000 | call | Halozyme Therapeutics Inc. | - | 48.704% | 0.424 | -0.036 | 7.913 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE0YPE | Halozyme Therapeutics Inc./OS/Call [86]/JPMD | - | - | 86.000 | call | Halozyme Therapeutics Inc. | - | 51.807% | 0.513 | -0.025 | 4.549 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE0V86 | Halozyme Therapeutics Inc./OS/Call [88]/JPMD | - | - | 88.000 | call | Halozyme Therapeutics Inc. | - | 50.328% | 0.384 | -0.036 | 8.010 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE111F | Halozyme Therapeutics Inc./OS/Call [88]/JPMD | - | - | 88.000 | call | Halozyme Therapeutics Inc. | - | 52.254% | 0.444 | -0.024 | 4.817 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE0YP7 | Halozyme Therapeutics Inc./OS/Call [90]/JPMD | - | - | 90.000 | call | Halozyme Therapeutics Inc. | - | 52.445% | 0.457 | -0.025 | 4.757 | 12/18/2026 | 0.100 | JP Morgan | ||
| JY10S1 | Halozyme Therapeutics Inc./OS/Call [90]/JPMD | - | - | 90.000 | call | Halozyme Therapeutics Inc. | - | 51.369% | 0.346 | -0.035 | 8.185 | 09/18/2026 | 0.100 | JP Morgan | ||
| JY2E1G | Halozyme Therapeutics Inc./OS/Call [90]/JPMD | - | - | 90.000 | call | Halozyme Therapeutics Inc. | - | 62.099% | 0.304 | -0.056 | 9.801 | 08/21/2026 | 0.100 | JP Morgan | ||
| MM26P5 | | Halozyme Therapeutics Inc./OS/Call [90]/MS | - | - | 90.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM26P6 | | Halozyme Therapeutics Inc./OS/Call [90]/MS | - | - | 90.000 | call | Halozyme Therapeutics Inc. | - | 50.146% | 0.409 | -0.022 | 5.163 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MM5J61 | | Halozyme Therapeutics Inc./OS/Call [90]/MS | - | - | 90.000 | call | Halozyme Therapeutics Inc. | - | 54.307% | 0.358 | -0.038 | 7.692 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN0310 | | Halozyme Therapeutics Inc./OS/Call [90]/MS | - | - | 90.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN6DYH | | Halozyme Therapeutics Inc./OS/Call [90]/MS | - | - | 90.000 | call | Halozyme Therapeutics Inc. | - | 49.754% | 0.473 | -0.018 | 4.013 | 03/19/2027 | 0.100 | Morgan Stanley | |
| JE111C | Halozyme Therapeutics Inc./OS/Call [92]/JPMD | - | - | 92.000 | call | Halozyme Therapeutics Inc. | - | 52.208% | 0.433 | -0.024 | 4.886 | 12/18/2026 | 0.100 | JP Morgan | ||
| JY10S2 | Halozyme Therapeutics Inc./OS/Call [92]/JPMD | - | - | 92.000 | call | Halozyme Therapeutics Inc. | - | 52.920% | 0.314 | -0.035 | 8.249 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE111E | Halozyme Therapeutics Inc./OS/Call [94]/JPMD | - | - | 94.000 | call | Halozyme Therapeutics Inc. | - | 54.179% | 0.387 | -0.023 | 4.932 | 12/18/2026 | 0.100 | JP Morgan | ||
| MM3GSJ | | Halozyme Therapeutics Inc./OS/Call [95]/MS | - | - | 95.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM3GSK | | Halozyme Therapeutics Inc./OS/Call [95]/MS | - | - | 95.000 | call | Halozyme Therapeutics Inc. | - | 49.644% | 0.384 | -0.022 | 5.349 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MN2Z3C | | Halozyme Therapeutics Inc./OS/Call [95]/MS | - | - | 95.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN2Z3D | | Halozyme Therapeutics Inc./OS/Call [95]/MS | - | - | 95.000 | call | Halozyme Therapeutics Inc. | - | 57.610% | 0.288 | -0.036 | 7.869 | 09/18/2026 | 0.100 | Morgan Stanley | |
| MR3CU8 | | Halozyme Therapeutics Inc./OS/Call [95]/MS | - | - | 95.000 | call | Halozyme Therapeutics Inc. | - | - | - | - | - | 03/19/2027 | 0.100 | Morgan Stanley | |
| JE111Q | Halozyme Therapeutics Inc./OS/Call [96]/JPMD | - | - | 96.000 | call | Halozyme Therapeutics Inc. | - | 51.971% | 0.384 | -0.023 | 5.149 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE8Z1R | Halozyme Therapeutics Inc./OS/Call [98]/JPMD | - | - | 98.000 | call | Halozyme Therapeutics Inc. | - | 52.801% | 0.364 | -0.023 | 5.181 | 12/18/2026 | 0.100 | JP Morgan | ||
| MM26RY | | Halozyme Therapeutics Inc./OS/Put [50]/MS | - | - | 50.000 | put | Halozyme Therapeutics Inc. | - | 74.400% | -0.138 | -0.010 | 1.956 | 06/17/2027 | 0.100 | Morgan Stanley | |
| MM26RZ | | Halozyme Therapeutics Inc./OS/Put [50]/MS | - | - | 50.000 | put | Halozyme Therapeutics Inc. | - | 81.225% | -0.111 | -0.016 | 3.146 | 12/18/2026 | 0.100 | Morgan Stanley | |
| MN5C5Y | | Halozyme Therapeutics Inc./OS/Put [50]/MS | - | - | 50.000 | put | Halozyme Therapeutics Inc. | - | 83.497% | -0.150 | -0.010 | 1.142 | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN6G49 | | Halozyme Therapeutics Inc./OS/Put [50]/MS | - | - | 50.000 | put | Halozyme Therapeutics Inc. | - | 75.495% | -0.127 | -0.012 | 2.442 | 03/19/2027 | 0.100 | Morgan Stanley | |
| JE0LBK | Halozyme Therapeutics Inc./OS/Put [64]/JPMD | - | - | 64.000 | put | Halozyme Therapeutics Inc. | - | 71.042% | -0.159 | -0.029 | 5.937 | 09/18/2026 | 0.100 | JP Morgan |